Tags

Type your tag names separated by a space and hit enter

Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring.
J Mass Spectrom Adv Clin Lab. 2023 Apr; 28:99-104.JM

Abstract

INTRODUCTION

Therapeutic drug monitoring (TDM) of immunosuppressants is essential for optimal care of transplant patients. Immunoassays and liquid chromatography-mass spectrometry (LC-MS) are the most commonly used methods for TDM. However, immunoassays can suffer from interference from heterophile antibodies and structurally similar drugs and metabolites. Additionally, nominal-mass LC-MS assays can be difficult to optimize and are limited in the number of detectable compounds.

OBJECTIVES

The aim of this study was to implement a mass spectrometry-based test for immunosuppressant TDM using online solid-phase extraction (SPE) and accurate-mass full scan-single ion monitoring (FS-SIM) data acquisition mode.

METHODS

LC-MS analysis was performed on a TLX-2 multi-channel HPLC with a Q-Exactive Plus mass spectrometer. TurboFlow online SPE was used for sample clean up. The accurate-mass MS was set to positive electrospray ionization mode with FS-SIM for quantitation of tacrolimus, sirolimus, everolimus, and cyclosporine A. MS2 fragmentation pattern was used for compound confirmation.

RESULTS

The method was validated in terms of precision, analytical bias, limit of quantitation, linearity, carryover, sample stability, and interference. Quantitation of tacrolimus, sirolimus, everolimus, and cyclosporine A correlated well with results from an independent reference laboratory (r = 0.926-0.984).

CONCLUSIONS

Accurate-mass FS-SIM can be successfully utilized for immunosuppressant TDM with good correlation with results generated by standard methods. TurboFlow online SPE allows for a simple "protein crash and shoot" sample preparation protocol. Compared to traditional MRM, analyte quantitation by FS-SIM facilitates a streamlined assay optimization process.

Authors+Show Affiliations

Department of Pathology, Stanford University, Stanford, CA, USA. Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA.Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA.Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA.Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA.Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA.Department of Pathology, Stanford University, Stanford, CA, USA. Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA.Department of Pathology, Stanford University, Stanford, CA, USA. Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA.Department of Pathology, Stanford University, Stanford, CA, USA. Clinical Laboratories, Stanford Health Care, Palo Alto, CA, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

36937810

Citation

Yeung, Priscilla S-W, et al. "Mass Spectrometry Quantitation of Immunosuppressive Drugs in Clinical Specimens Using Online Solid-phase Extraction and Accurate-mass Full Scan-single Ion Monitoring." Journal of Mass Spectrometry and Advances in the Clinical Lab, vol. 28, 2023, pp. 99-104.
Yeung PS, Miller P, Lai-Nyugen TB, et al. Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring. J Mass Spectrom Adv Clin Lab. 2023;28:99-104.
Yeung, P. S., Miller, P., Lai-Nyugen, T. B., Cheng, P., Ibrahim, A., Shi, R. Z., Bowen, R. A. R., & Luo, R. Y. (2023). Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring. Journal of Mass Spectrometry and Advances in the Clinical Lab, 28, 99-104. https://doi.org/10.1016/j.jmsacl.2023.03.002
Yeung PS, et al. Mass Spectrometry Quantitation of Immunosuppressive Drugs in Clinical Specimens Using Online Solid-phase Extraction and Accurate-mass Full Scan-single Ion Monitoring. J Mass Spectrom Adv Clin Lab. 2023;28:99-104. PubMed PMID: 36937810.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring. AU - Yeung,Priscilla S-W, AU - Miller,Paige, AU - Lai-Nyugen,Tran Bao, AU - Cheng,Phil, AU - Ibrahim,Amira, AU - Shi,Run-Zhang, AU - Bowen,Raffick A R, AU - Luo,Ruben Yiqi, Y1 - 2023/03/07/ PY - 2023/2/10/received PY - 2023/3/3/revised PY - 2023/3/5/accepted PY - 2023/3/20/entrez PY - 2023/3/21/pubmed PY - 2023/3/21/medline KW - Accurate-mass KW - CAP, College of American Pathologists KW - CLSI, Clinical & Laboratory Standards Institute KW - CV, coefficient of variation KW - ESI, electrospray ionization KW - FS-SIM, full scan-single ion monitoring KW - Full scan single-ion monitoring KW - HCD, high-energy C-trap dissociation KW - IRB, Institutional Review Board KW - Immunosuppressive drugs KW - LC-MS, liquid chromatography-mass spectrometry KW - LDT, laboratory developed test KW - MRM, multiple reaction monitoring KW - Mass spectrometry KW - Online solid-phase extraction KW - SD, standard deviation KW - SPE, solid-phase extraction KW - TDM, therapeutic drug monitoring KW - Therapeutic drug monitoring SP - 99 EP - 104 JF - Journal of mass spectrometry and advances in the clinical lab JO - J Mass Spectrom Adv Clin Lab VL - 28 N2 - INTRODUCTION: Therapeutic drug monitoring (TDM) of immunosuppressants is essential for optimal care of transplant patients. Immunoassays and liquid chromatography-mass spectrometry (LC-MS) are the most commonly used methods for TDM. However, immunoassays can suffer from interference from heterophile antibodies and structurally similar drugs and metabolites. Additionally, nominal-mass LC-MS assays can be difficult to optimize and are limited in the number of detectable compounds. OBJECTIVES: The aim of this study was to implement a mass spectrometry-based test for immunosuppressant TDM using online solid-phase extraction (SPE) and accurate-mass full scan-single ion monitoring (FS-SIM) data acquisition mode. METHODS: LC-MS analysis was performed on a TLX-2 multi-channel HPLC with a Q-Exactive Plus mass spectrometer. TurboFlow online SPE was used for sample clean up. The accurate-mass MS was set to positive electrospray ionization mode with FS-SIM for quantitation of tacrolimus, sirolimus, everolimus, and cyclosporine A. MS2 fragmentation pattern was used for compound confirmation. RESULTS: The method was validated in terms of precision, analytical bias, limit of quantitation, linearity, carryover, sample stability, and interference. Quantitation of tacrolimus, sirolimus, everolimus, and cyclosporine A correlated well with results from an independent reference laboratory (r = 0.926-0.984). CONCLUSIONS: Accurate-mass FS-SIM can be successfully utilized for immunosuppressant TDM with good correlation with results generated by standard methods. TurboFlow online SPE allows for a simple "protein crash and shoot" sample preparation protocol. Compared to traditional MRM, analyte quantitation by FS-SIM facilitates a streamlined assay optimization process. SN - 2667-145X UR - https://www.unboundmedicine.com/medline/citation/36937810/Mass_spectrometry_quantitation_of_immunosuppressive_drugs_in_clinical_specimens_using_online_solid_phase_extraction_and_accurate_mass_full_scan_single_ion_monitoring_ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.